---
created: '2026-02-09T05:40:20.735420Z'
description: Tumor Necrosis Factor Alpha is a pro-inflammatory cytokine produced primarily
  by activated macrophages, playing a central role in systemic inflammation and immune
  cell regulation.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/biomarker/tnf-alpha/
slug: tnf-alpha
tags:
- biomarker
templateEngineOverride: njk
title: TNF Alpha
type: biomarker
updated: '2026-02-09T05:40:20.735420Z'
---

{% raw %}
<h1>TNF Alpha</h1>
<h2>Overview</h2>
<p>Tumor Necrosis Factor Alpha (TNF-alpha) is a potent pro-inflammatory cytokine primarily produced by activated macrophages, though it is also secreted by monocytes, T lymphocytes, natural killer cells, and adipocytes. It is a master regulator of the inflammatory cascade, capable of inducing fever, apoptosis, cachexia, and the production of other pro-inflammatory cytokines including IL-1, IL-6, and IL-8.</p>
<p>TNF-alpha signals through two receptors: TNFR1 (expressed on most tissues, mediates apoptosis and inflammation) and TNFR2 (primarily on immune cells, mediates cell survival and proliferation). Dysregulated TNF-alpha production is a key driver of chronic inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease (Crohn's disease and ulcerative colitis), psoriasis, and ankylosing spondylitis.</p>
<p>The clinical importance of TNF-alpha is underscored by the success of anti-TNF biological therapies (infliximab, adalimumab, etanercept), which are among the most prescribed biologics worldwide. Measuring circulating TNF-alpha levels can help assess inflammatory burden, though levels are highly variable and must be interpreted in clinical context.</p>
<h2>Reference Ranges</h2>
<table>
<thead>
<tr>
<th>Range</th>
<th>Value</th>
<th>Interpretation</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Low</strong></td>
<td>&lt;1.0 pg/mL</td>
<td>Minimal TNF-alpha activity</td>
</tr>
<tr>
<td><strong>Normal</strong></td>
<td>&lt;8.1 pg/mL</td>
<td>No significant systemic TNF-alpha elevation</td>
</tr>
<tr>
<td><strong>High</strong></td>
<td>&gt;8.1 pg/mL</td>
<td>Active inflammatory or autoimmune process</td>
</tr>
<tr>
<td><strong>Optimal</strong></td>
<td>&lt;4.0 pg/mL</td>
<td>Low inflammatory burden</td>
</tr>
</tbody>
</table>
<h2>Testing Information</h2>
<ul>
<li><strong>Measurement Unit</strong>: pg/mL</li>
<li><strong>Sample Type</strong>: Serum</li>
<li><strong>Fasting Required</strong>: False</li>
<li><strong>Recommended Test Frequency</strong>: As needed; useful for monitoring autoimmune disease activity and response to anti-TNF therapy</li>
</ul>
<h2>ðŸ’Š Supplements That Affect This Biomarker</h2>
<ul>
<li>[[Curcumin]] - Decreases TNF-alpha by inhibiting NF-kB and MAPK signaling (moderate, evidence level 3)</li>
<li>[[Omega-3 Fatty Acids]] - Decreases TNF-alpha production through EPA/DHA-mediated anti-inflammatory pathways (moderate, evidence level 3)</li>
<li>[[Resveratrol]] - Decreases TNF-alpha in metabolic syndrome through SIRT1 activation and NF-kB suppression (mild, evidence level 3)</li>
</ul>
<h2>ðŸ§ª Lab Tests That Measure This Biomarker</h2>
<h3>Direct Tests</h3>
<ul>
<li>[[tnf alpha]] - TNF-alpha immunoassay (ELISA or multiplex cytokine panel)</li>
</ul>
<h3>Panel Tests</h3>
<ul>
<li>[[advanced inflammation panel]] (labtestpanel) - Includes TNF-alpha in comprehensive cytokine assessment</li>
</ul>
<h2>Relationships</h2>
<h3>Activates</h3>
<ul>
<li>â†’ [[Interleukin 6]] (biomarker)</li>
<li>â†’ [[Hs Crp]] (biomarker)</li>
</ul>
<h3>Correlations</h3>
<ul>
<li>â†’ [[Interleukin 6]] (biomarker) - TNF-alpha stimulates IL-6 production; both are elevated in systemic inflammation</li>
<li>â†’ [[Hs Crp]] (biomarker) - TNF-alpha indirectly elevates CRP through IL-6 stimulation of hepatic CRP synthesis</li>
</ul>
<h2>References</h2>
<ul>
<li>PMID:31799018 - White CM et al. Oral curcumin as an adjunctive therapy for inflammatory conditions. Pharmacotherapy. 2019.</li>
<li>PMID:27392742 - Sahebkar A et al. Effect of curcuminoids on oxidative stress and inflammatory markers. Crit Rev Food Sci Nutr. 2016.</li>
<li>PMID:22317966 - Li K et al. Effect of marine-derived n-3 polyunsaturated fatty acids on inflammatory markers. PLoS One. 2014.</li>
<li>PMID:29210129 - Haghighatdoost F et al. Effect of resveratrol on metabolic syndrome components. Ann N Y Acad Sci. 2018.</li>
</ul>
<h2>Dataview Queries</h2>
<pre><code class="language-dataview">LIST
FROM [[TNF Alpha]]
WHERE contains(type, &quot;Intervention&quot;)
SORT confidence_score DESC
</code></pre>

{% endraw %}